ArticleFrontiers in immunology2026

Integrated cellular, proteomic and metabolomic profiling of immune-related adverse events in non-small cell lung cancer.

Natalie J Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.